Product Information
POTASSIUM CL ER 10 MEQ CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.1374 per EA under NDC 00904754361. Its NADAC has been published 38 times since Jan 14, 2026.
FDA first approved this application on Feb 22, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904754361
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202128FDA Approved
2/22/2013
TE Code
AB
On Market Since
9/18/2025
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 10 MEQ CAPSULE has been published 38 times since Jan 14, 2026, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1374 per EA |
|---|---|
| All-time high | $0.1374 (Sep 30, 2026) |
| All-time low | $0.1239 (Jan 14, 2026) |
| 52-week high | $0.1374 |
| 52-week low | $0.1239 |
| Median price | $0.1328 |
| Average price | $0.1321 |
| Largest weekly change | +4.4% (Apr 22, 2026) |
| Weeks tracked | 38 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 10 MEQ CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ CAPSULE, manufactured by Major Pharmaceuticals, is $0.1374 per EA (NDC 00904754361), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 10 MEQ CAPSULE changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ CAPSULE has risen 10.9%. It has been tracked across 38 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ CAPSULE?
Since Jan 14, 2026, the NADAC for POTASSIUM CL ER 10 MEQ CAPSULE has ranged from a low of $0.1239 (Jan 14, 2026) to a high of $0.1374 (Sep 30, 2026), with a median of $0.1328 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ CAPSULE, is $0.1241 per EA — about 10% below POTASSIUM CL ER 10 MEQ CAPSULE.
Who manufactures POTASSIUM CL ER 10 MEQ CAPSULE?
POTASSIUM CL ER 10 MEQ CAPSULE (NDC 00904754361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.